4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Caris Life Sciences, Inc. (CAI) operates in the Biotechnology industry and is headquartered in Irving, United States with about 1,846 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2025-12-31, CAI reported $812M in revenue and ($68M) in net income.
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms.
Interactive charts & full statements → Open the CAI valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $812M | $412M | $306M | $258M |
| Gross Profit | $539M | $179M | $89M | $80M |
| Operating Income (EBIT) | $45M | ($257M) | ($320M) | ($316M) |
| Net Income | ($68M) | ($282M) | ($341M) | ($321M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $216M | $293M | $217M | $181M | $121M |
| Gross Profit | $141M | $221M | $148M | $114M | $57M |
| Operating Income (EBIT) | $5M | $88M | $33M | ($18M) | ($58M) |
| Net Income | ($0M) | $82M | $24M | ($72M) | ($103M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $1.1B | $344M | $413M | $717M |
| Total Liabilities | $548M | $2.8B | $2.6B | $2.4B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CAI viewer.
About TickerBase · Data methodology & sources